Sinovac Biotech from China seeks co-financing for COVID-19 vaccine trial in Bangladesh


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ chinese-vaccine-company-sinovac-biotech-seeks-cofinancing-covid19-vaccine-trial-in-bangladesh
The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine

The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine.

The company was given permission to carry out the phase-3 human trial about a month back by the government.

Responding to an unconfirmed report about the Chinese company asking for co-financing for a vaccine trial, the Health Division Secretary of the government of Bangladesh Abdul Mannan confirmed to the official news agency BSS yesterday that Sinovac Biotech Ltd has sent a letter to the government seeking co-financing for COVID 19 vaccine trial.

He said that the company had not asked for co-financing by the Bangladesh government when it obtained the approval to carry out the trial.

The Chinese company had originally put up the proposal to Bangladesh through the Dhaka based International Centre for Diarrheal Disease Research, Bangladesh (ICDDR’B). The government granted final clearance for the clinical trial on August 27.

An official of the ICDDR’B told BSS that it is now entirely up to the government to decide if they will agree to the co-financing proposal as there was no mention of it in the original proposal of the Chinese company.

Under the agreement before the co-financing was sought, Bangladesh would have got one lakh vaccines for free. It would also have got priority to purchase adequate quantum of vaccines from the Chinese company Sinovac Biotech.

Meanwhile, Bangladesh Govt has issued directives restricting certain activities in view of the security, law and order and COVID-19 pandemic during the upcoming Durga Puja in the country. The directives came after the meeting Chaired by Home Minister Asaduzzamn Khan on Sunday in Dhaka.

The meeting requested the leaders of the nationwide Sarbajanin Puja Committee to limit the number of Puja mandaps as much as possible. The government has also decided that no procession will be allowed during the immersion of the idol at the end of the Durga Puja, said the press release issued by the Home Ministry.

The meeting decided that the Puja Celebration Committee will take steps to reduce the number of public gatherings at the Puja Mandap and to broadcast the Anjali program live. The organisers have been asked to maintain health guidelines such as social distancing, wearing of masks and using the hand sanitiser for people visiting the mandaps.

Police forces will be on mobile duty to deal with law and order situations. The guidelines also require that various ceremonies should be held maintaining religious harmony. The Puja Udjapan Committee will be coordinating with the local administration and law enforcement agencies for the management of the mandaps.

Tags : #SinivacBiotech #China #Bangladesh #COVID-19Vaccine #Phase-3Trial #LatestPharmaNews5thOct #LatestCOVIDNews5thOct

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026
How Can Diabetes and High Blood Pressure Quietly Lead to Kidney Failure?September 30, 2026
Apollo Hospitals’ “My Hands Are Ready” Sets World Record Title with 61,221 CPR Pledges in 30 DaysSeptember 30, 2026
How Medical Device Trials and Validation Shape Safer Healthcare Innovation in IndiaSeptember 30, 2026
Medical Device Safety in India: What Patients Should Know About Recalls and AlertsSeptember 30, 2026
Smart Implants: How Connected Devices Could Transform Follow-Up Care in IndiaSeptember 30, 2026
Single-Use Medical Devices: Innovation, Cost and Sustainability in Indian HealthcareSeptember 30, 2026
11th National Convention on Medicine & Law 2026 Successfully Concludes at D Y Patil University, Navi MumbaiSeptember 29, 2026
Can Your Skin Show the Signs of Chronic Stress? Dermatologists Explain What to Watch ForSeptember 29, 2026
MDI Gurgaon’s Samvaad X ScaNxt NXT STEP to Put Strategic Decision-Making Under Polycrisis Conditions to TestSeptember 29, 2026
Point-of-Care Diagnostics in India: Bringing Faster Testing Closer to PatientsSeptember 29, 2026
Adult Vaccination in India: The Preventive Care Gap Beyond ChildhoodSeptember 29, 2026
Maternal Nutrition Beyond Iron and Folic Acid: What Modern Prenatal Care in India Should IncludeSeptember 29, 2026